Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

Journal of endocrinological investigation

Volumn 26, Issue 8 Suppl, 2003, Pages 63-69

  Bombardieri, E ^a   Seregni, E ^a   Savelli, G ^a   Villano, C ^a   Castellani, M R ^a   Cirillo, F ^a   Pallotti, F ^a   Fracassi, S ^a   Chiesa, C ^a   Chiti, A ^a   Bajetta, E ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; INDIUM; PENTETREOTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN;

ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; ITALY; MALE; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; RADIATION DOSE; SCINTISCANNING;

ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INDIUM RADIOISOTOPES; ITALY; MALE; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; SOMATOSTATIN;

EID: 3543070432     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)